Astrego is a fast growing in vitro diagnostics company based in Uppsala. After a decade of basic research, the company was founded in 2017 with the mission to help in the global fight against antimicrobial resistance (AMR).
Atrego’s products are designed to guide physicians in choosing effective antibiotic treatments to improve patient outcomes and make it easy to administer antibiotics. The company name Astrego comes from Antibiotic Susceptibility Testing – AST, and rego – Latin for guide, control or management.
STATUS: Exit
